| P2093 | author name string | Nehal N Mehta | |
| | James D Otvos | |
| | Martin P Playford | |
| | Margery A Connelly | |
| | Irina Shalaurova | |
| P2860 | cites work | Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons | Q21562282 |
| | Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer | Q26745646 |
| | Acute-phase proteins and other systemic responses to inflammation | Q28296941 |
| | Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma | Q28338019 |
| | A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome. | Q51300594 |
| | GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. | Q51302920 |
| | A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. | Q51345951 |
| | Biological Variation of Acute Phase Proteins | Q72096184 |
| | A novel protein glycan biomarker and LCAT activity in metabolic syndrome | Q85392348 |
| | Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects | Q89249937 |
| | Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis | Q33857000 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies | Q34318384 |
| | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment | Q34563216 |
| | Time variability of C-reactive protein: implications for clinical risk stratification | Q34665888 |
| | Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 |
| | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 |
| | A novel protein glycan biomarker and future cardiovascular disease events | Q35070814 |
| | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study | Q35554431 |
| | GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes | Q35587378 |
| | Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus | Q35637841 |
| | Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis | Q35652911 |
| | GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function | Q35784924 |
| | Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children | Q36123376 |
| | Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality | Q36208044 |
| | GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus | Q36619510 |
| | Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy | Q36759420 |
| | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls | Q36790408 |
| | Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial | Q37240800 |
| | Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 |
| | High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis | Q37775403 |
| | Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? | Q38287565 |
| | Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics | Q38359651 |
| | GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation | Q38387364 |
| | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 |
| | Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events | Q38867958 |
| | The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection | Q38872925 |
| | GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study | Q38944790 |
| | Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis | Q39020908 |
| | Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion | Q39056510 |
| | Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women | Q40295949 |
| | Psoriasis and cardiovascular events: updating the evidence. | Q40329572 |
| | GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. | Q40571559 |
| | Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. | Q44547380 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | carbohydrate | Q11358 |
| | cardiovascular disease | Q389735 |
| | biomarker | Q864574 |
| | systemic inflammation | Q7663815 |
| P304 | page(s) | 219 | |
| P577 | publication date | 2017-10-27 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk | |
| P478 | volume | 15 | |